Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 1 client • 6 examiners • 3 art units • 0 of 7 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Wideband IP Office handles patent prosecution in the Biotechnology & Pharmaceuticals technology area, with 146 career applications on record. The firm has a resolved allowance rate of 67.03 percent. Its prosecution history shows an average of 2.79 office actions per allowance. Currently, the firm is managing 5 pending office actions.
The 146 career applications and 67.03 percent allowance rate establish the firm's historical performance in this sector. The 2.79 average helps practitioners understand the typical procedural requirements for reaching an allowance. With 5 pending office actions, the firm maintains its presence in Biotechnology & Pharmaceuticals. This data set reflects the firm's documented experience and current workload within the patent office. The recorded metrics provide a baseline for procedural duration in this specific field. Practitioners can evaluate the intensity of examiner interaction and resource requirements based on these historical figures. These statistics offer a view of the firm's prosecution profile.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (29%) |
| §102 only | 1 (14%) |
| Multi-statute (no §101) | 4 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SPAINE, ROBERT FRANKLIN | 2 | 75.0% | +0.0% |
| CRUM, MARY ABOU NADER | 1 | 40.4% | +65.0% |
| HOFFMAN, SUSAN COE | 1 | 54.2% | +25.6% |
| TRAN, SUSAN T | 1 | 62.8% | +35.1% |
| CHEN, CATHERYNE | 1 | 37.4% | +18.0% |
| MOREAU, NASHARA LOUISE | 1 | 80.0% | -100.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18518451 | METHOD FOR REGULATING IMMUNITY BY USING BLACK HULLESS BARLEY EXTRACT | MOREAU, NASHARA LOUISE | 75d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18430680 | METHODS FOR SUPPLEMENTING IRON, PROMOTING IRON ABSORPTION, AND/OR IMPROVING SKIN CONDITION BY USING SASKATOON BERRY EXTRACT | HOFFMAN, SUSAN COE | 12d |
| 18395764 | METHODS FOR IMPROVING BONE QUALITY AND PROMOTING CARTILAGE DIFFERENTIATION BY CHRYSOPHYLLUM CAINITO EXTRACT AND MANUFACTURING METHOD THEREOF | CHEN, CATHERYNE | 14d |
| 18786581 | LACTOBACILLUS SAKEI TCI147 AND METHOD FOR IMPROVING SKIN CONDITION BY USING LACTOBACILLUS SAKEI TCI147 AND/OR METABOLITES THEREOF | CRUM, MARY ABOU NADER | — |
| 18528783 | METHODS FOR RESISTING SKIN AGING BY USING KIWIBERRY EXTRACT | SPAINE, ROBERT FRANKLIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18430680 | METHODS FOR SUPPLEMENTING IRON, PROMOTING IRON ABSORPTION, AND/OR IMPROVING SKIN CONDITION BY USING SASKATOON BERRY EXTRACT | HOFFMAN, SUSAN COE | 12d |
| 18395764 | METHODS FOR IMPROVING BONE QUALITY AND PROMOTING CARTILAGE DIFFERENTIATION BY CHRYSOPHYLLUM CAINITO EXTRACT AND MANUFACTURING METHOD THEREOF | CHEN, CATHERYNE | 14d |
| 18786581 | LACTOBACILLUS SAKEI TCI147 AND METHOD FOR IMPROVING SKIN CONDITION BY USING LACTOBACILLUS SAKEI TCI147 AND/OR METABOLITES THEREOF | CRUM, MARY ABOU NADER | — |
| 18426360 | METHODS FOR ENHANCING SKIN RESISTANCE, IMPROVING SKIN SMOOTHNESS, OR IMPROVING SKIN BRIGHTNESS BY USING AMPELOPSIS GROSSEDENTATA LEAF EXTRACT | TRAN, SUSAN T | — |
| Client (Assignee) | Pending OAs |
|---|---|
| TCI CO., LTD. | 7 |
| Art Unit | Apps |
|---|---|
| 1655 | 5 |
| 1657 | 1 |
| 1615 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18786581 | LACTOBACILLUS SAKEI TCI147 AND METHOD FOR IMPROVING SKIN CONDITION BY USING LACTOBACILLUS SAKEI TCI147 AND/OR METABOLITES THEREOF | Tci Co., Ltd. | CRUM, MARY ABOU NADER | 1657 | §103§112 | Non-Final OA | — | Pending | Jul 29, 2024 |
| 18430680 | METHODS FOR SUPPLEMENTING IRON, PROMOTING IRON ABSORPTION, AND/OR IMPROVING SKIN CONDITION BY USING SASKATOON BERRY EXTRACT | Tci Co., Ltd. | HOFFMAN, SUSAN COE | 1655 | §103§112 | Final Rejection | 12d | Pending | Feb 02, 2024 |
| 18426360 | METHODS FOR ENHANCING SKIN RESISTANCE, IMPROVING SKIN SMOOTHNESS, OR IMPROVING SKIN BRIGHTNESS BY USING AMPELOPSIS GROSSEDENTATA LEAF EXTRACT | Tci Co., Ltd. | TRAN, SUSAN T | 1615 | §102 | Final Rejection | — | Pending | Jan 30, 2024 |
| 18409817 | METHODS FOR IMPROVING SLEEP QUALITY, INCREASING MITOCHONDRIAL EXPRESSION, PROMOTING CELL REPAIRING, OR FIRMING SKIN BY USING SPARASSIA CRISPA EXTRACT | Tci Co., Ltd. | SPAINE, ROBERT FRANKLIN | 1655 | §103 | Final Rejection | 13d | Pending | Jan 11, 2024 |
| 18395764 | METHODS FOR IMPROVING BONE QUALITY AND PROMOTING CARTILAGE DIFFERENTIATION BY CHRYSOPHYLLUM CAINITO EXTRACT AND MANUFACTURING METHOD THEREOF | Tci Co., Ltd. | CHEN, CATHERYNE | 1655 | §103§112 | Final Rejection | 14d | Pending | Dec 26, 2023 |
| 18528783 | METHODS FOR RESISTING SKIN AGING BY USING KIWIBERRY EXTRACT | Tci Co., Ltd. | SPAINE, ROBERT FRANKLIN | 1655 | §102§103§112 | Non-Final OA | — | Pending | Dec 05, 2023 |
| 18518451 | METHOD FOR REGULATING IMMUNITY BY USING BLACK HULLESS BARLEY EXTRACT | Tci Co., Ltd. | MOREAU, NASHARA LOUISE | 1655 | §103 | Non-Final OA | 75d | Pending | Nov 23, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial